Saturday, November 9


Click titles of paper presentations and symposia to view abstracts and outlines.

« Click to Return to Friday’s Schedule

Times and topics are subject to change.*

 

5:30 a.m. Check-in
5:55 a.m. Start
5K Fun Run and 1 Mile Walk Benefiting Operation Walk
Check in behind the Hilton Garden Inn located across Wycliffe Ave. from the Anatole. Follow signs to exit the Anatole through the west door (past the Cortez meeting room).
Trinity Strand Trail
6:00 a.m. – 7:30 p.m. Registration Peacock Foyer
6:00 – 7:00 a.m. Breakfast for All Attendees
Hosted by Operation Walk
Learning Center/Exhibit Hall
6:00 a.m. – 6:00 p.m. Learning Center/Exhibit Hall Open Learning Center/Exhibit Hall
6:00 – 7:00 a.m. Informal AAHKS Committee Meetings and Breakfast
(Committee Members Only)
Coral Meeting Room
(In corner near the elephants)
6:00 a.m. – 8:00 p.m. AAHKS and Guest Societies Poster Exhibition Chantilly Ballroom
7:00 a.m. – 4:00 p.m.
Check-in at 6:30 a.m.
Orthopaedic In-Training Scored and Recorded Examination (OITE)
This is an option for residents attending the Annual Meeting. AAHKS is an approved host for the OITE.
Grand Ballroom ABCDE
6:55 – 7:00 a.m. Program Chair’s Welcome to the 2019 AAHKS Annual Meeting
James A. Browne, MD
Trinity Ballroom
7:00 – 8:02 a.m. Session Two: Primary Total Hip Arthroplasty Moderators:
Matthew S. Austin, MD
William A. Jiranek, MD, FACS
7:00 a.m.
Paper #9
Pain Control After Total Hip Arthroplasty: A Randomized Trial Determining Efficacy of Fascia Iliaca Compartment Blocks in the Immediate Postoperative Period Kamil Bober, MD
Detroit, MI
7:06 a.m.
Paper #10
Topical Tranexamic Acid Increases Early Postoperative Pain After Total Hip Arthroplasty R. Michael Meneghini, MD
Indianapolis, IN
7:12 a.m.
Paper #11
Risk of Dislocation by Surgical Approach Following Modern Primary Total Hip Arthroplasty Michael J. Taunton, MD
Rochester, MN 
7:18 a.m. Discussion
7:28 a.m.
Paper #12
The Majority of Total Hip Arthroplasty Patients with a Stiff Spine Do Not Have an Instrumented Fusion Douglas A. Dennis, MD
Denver, CO
7:34 a.m.
Paper #13
The Effect of Preoperative Anemia on Complications Following Total Hip Arthroplasty Matthew J. Grosso, MD
New York, NY
7:40 a.m.
Paper #14
Does Femoral Morphology Predict the Risk of Periprosthetic Fracture After Cementless Total Hip Arthroplasty? Denis Nam, MD, MSc
Chicago, IL
7:46 a.m.
Paper #15
Does Femoral Component Cementation Affect Costs or Clinical Outcomes After Hip Arthroplasty in Medicare Patients? Matthew S. Hepinstall, MD
New York, NY 
7:52 a.m. Discussion
8:02 – 9:02 a.m. Symposium III: Total Knee Arthroplasty Removal from the Medicare Inpatient-Only (IPO) List: Implications for Surgeons, Patients, and Hospitals

  • Introduction
    Richard Iorio, MD
  • The Patient Impact Broken Down by Length of Stay and Population Segment
    Richard Iorio, MD
  • Analyzing the Adoption of Outpatient Total Knee Arthroplasty (TKA) Since 2018
    C. Lowry Barnes, MD
  • The Financial Implications for Surgeons and Hospitals and How This Is Influencing Current Practice
    Derek A. Haas, MBA
  • The Quality and Financial Impact at My Hospital
    Charles M. Davis, MD, PhD
  • Discussion
    Richard Iorio, MD
Moderator:
Richard Iorio, MD
Panelists:
Derek A. Haas, MBA
C. Lowry Barnes, MD
Charles M. Davis, MD, PhD
9:02 – 9:58 a.m. Session Three: Health Policy Moderators:
James I. Huddleston, MD
Richard Iorio, MD
9:02 a.m.
Paper #16
Removal of Total Knee Arthroplasty from the Inpatient Only List Adversely Affects Bundled Payment Programs Michael Yayac, MD
Philadelphia, PA
9:08 a.m.
Paper #17
The Clinical and Financial Consequences of the Centers for Medicare and Medicaid Services’ Two-Midnight Rule in Total Joint Arthroplasty Adam J. Schwartz, MD
Phoenix, AZ
9:14 a.m.
Paper #18
Surgeon Reimbursement Unchanged as Hospital Charges and Reimbursements Increase for Total Hip Arthroplasty Dennis Q. Chen, MD
Charlottesville, VA
9:20 a.m. Discussion
9:30 a.m.
Paper #19
Hospital Total Joint Arthroplasty Case-Mix Burden and Patient Flows in the Era of Payment Reform: Impact on Resource Utilization Among New York State Hospitals Calin S. Moucha, MD
New York, NY
9:36 a.m.
Paper #20
Are We Treating Similar Patients? Hospital Volume and the Difference in Patient Populations for Total Knee Arthroplasty Robert M. Molloy, MD
Cleveland, OH
9:42 a.m.
Paper #21
Reviews of Orthopedic Surgeons on Physician Rating Websites: Analysis of 11535 Reviews Atul F. Kamath, MD
Cleveland, OH
9:48 a.m. Discussion
9:58 – 10:10 a.m. Break Learning Center/Exhibit Hall
10:10 – 11:06 a.m. Session Four: Primary Total Knee Arthroplasty and Complications Moderators:
Bryan D. Springer, MD
Adolph J. Yates, Jr., MD, FAOA
10:10 a.m.
Paper #22
Body Mass Index Is a Better Predictor of Periprosthetic Joint Infection Risk than Local Measures of Adipose Tissue Following Total Knee Arthroplasty Simon W. Young, MBChB, FRACS, MD
Auckland, New Zealand
10:16 a.m.
Paper #23
Fate of the Morbidly Obese Patient Who Is Denied Total Joint Arthroplasty Joshua A. Shapiro, MD
Chapel Hill, NC
10:22 a.m.
Paper #24
Primary Total Knee Arthroplasty Performed Using High-Viscosity Cement Is Associated with Higher Odds of Revision for Aseptic Loosening Leonard T. Buller, MD
New York, NY
10:28 a.m. Discussion
10:38 a.m.
Paper #25
Stiffness After Total Knee Arthroplasty: Is It a Result of Spinal Deformity? Jonathan M. Vigdorchik, MD
New York, NY
10:44 a.m.
Paper #26
Identification of Clinical and Biological Risk Factors for Postoperative Stiffness After Total Knee Arthroplasty for Osteoarthritis Meghan Kirksey, MD, PhD
New York, NY
10:50 a.m.
Paper #27
Manipulation Under Anesthesia After Total Knee Arthroplasty: Who Still Requires a Revision? David P. Brigati, MD
Austin, TX
10:56 a.m. Discussion
11:06 – 11:45 a.m. Keynote Session: AAHKS Town Hall Meeting
Topics:

  1. Site of Service – Inpatient vs. Outpatient vs. ASCs; Inpatient Only Lists; Two-Midnight Rule
  2. Value-Based Care – Bundled Payment Pilot Plans; Stark and Anti-Kickback Statute Reform; Gainsharing; Physician Ownership
  3. Payment Reforms – Fee for Service Payment and the RUC Process; Payment for Preoptimization Work
Moderator: Michael P. Bolognesi, MD
Academic Chair: C. Lowry Barnes, MD
Advocacy Chair: James I. Huddleston, MD
OP Surgery Center: Michael E. Berend, MD
Organized Medicine: David A. Halsey, MD
AAHKS Lobbyist: David McNitt
11:45 a.m. – 12:45 p.m. Lunch for All Attendees Learning Center/Exhibit Hall
12:45 – 1:41 p.m. Session Five: Infection Moderators:
Daniel J. Berry, MD
Samuel S. Wellman, MD
12:45 p.m.
Paper #28
Polymerase Chain Reaction Multiplex Provides Minimal Utility in Periprosthetic Joint Infection Diagnosis Beau J. Kildow, MD
Durham, NC
12:51 p.m.
Paper #29
Prospective, Multicenter, Adjudicator-Blinded Clinical Trial of the Alpha-Defensin Lateral Flow Test for Periprosthetic Infection Carl A. Deirmengian, MD
Philadelphia, PA
12:57 p.m.
Paper #30
Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection in Total Knee Arthroplasty Patients Carlos A. Higuera, MD
Cleveland, OH
1:03 p.m. Discussion
1:13 p.m.
Paper #31
Reinfection or Persistence of Periprosthetic Joint Infection? Next Generation Sequencing Reveals New Findings Karan Goswami, MD
Philadelphia, PA
1:19 p.m.
Paper #32
Antibiotic Susceptibility of Organisms Recovered in Culture from Patients with Acute Prosthetic Joint Infection Following Primary Total Knee Arthroplasty Charles M. Lawrie, MD
St. Louis, MO
1:25 p.m.
Paper #33
Cutibacterium acnes Colonization: Implications for Total Hip Arthroplasty Jacob M. Elkins, MD, PhD
Iowa City, IA
1:31 p.m. Discussion
1:41 – 1:51 p.m. AAHKS Health Policy Fellow Reports

  • Rapid Discharge and Outpatient Arthroplasty Introduce Burden of Care to the Surgeon
  • Quantifying Surgeon Work in Total Hip and Knee Arthroplasty: Where Do We Stand Today?
  • Cost Analysis of Bundled Care and Short Stay Total Joint Arthroplasty
Vasili Karas, MD, MS
Mohamad J. Halawi, MD
Stephen M. Engstrom, MD
1:51 – 2:00 p.m. AAHKS Presidential Award Presented by:
Michael P. Bolognesi, MD
2:00 – 2:45 p.m. Symposium IV: The Current State of Practice Patterns of AAHKS Members Moderator:
Jay R. Lieberman, MD
2:45 – 2:51 p.m. AJRR Update Kevin J. Bozic, MD, MBA
2:51 p.m. The James A. Rand Young Investigator’s Award
Traditional Intravenous Fluid vs. Oral Fluid Administration in Primary Total Knee Arthroplasty: A Randomized Trial

Jason M. Jennings, MD
Denver, CO
Presented by:
Matthew P. Abdel, MD
2:57 p.m. Discussion
3:02 p.m. The Lawrence D. Dorr Surgical Techniques & Technologies Award
Aseptic Reoperations Within One Year of Primary Total Hip Arthroplasty Markedly Increase the Risk of Later Periprosthetic Joint Infection

Ashton H. Goldman, MD
Portsmouth, VA
Presented by:
Lawrence D. Dorr, MD
3:08 p.m. Discussion
3:13 p.m. The AAHKS Clinical Research Award
No Evidence for Higher Patient-Reported Outcome Scores After Total Hip Arthroplasty with the Direct Anterior Approach at 1.5 Months Postoperatively, and Through a 5-Year Follow-Up

Nicholas Sauder, BA
Boston, MA
Presented by:
Craig J. Della Valle, MD
3:19 p.m. Discussion
3:24 – 3:40 p.m. Break  Exhibit Hall/Learning Center
3:40 – 4:40 p.m. Symposium V: The Psychology of Total Joint Arthroplasty: Can We Modify Outcomes?

  • Moderator and Introduction
    Bryan D. Springer, MD
  • The Psychology of Total Joint Arthroplasty
    Bryan D. Springer, MD
  • Can Surgical Resilience Be Assessed and Shaped in Total Joint Arthroplasty
    Wayne M. Sotile, PhD
  • The Opioid Tolerant Patient: Preoperative Optimization
    Padma Gulur, MD
  • Discussion
    All faculty
Moderator: Bryan D. Springer, MD
Panelists:
Padma Gulur, MD
Wayne Sotile, PhD
4:40 – 5:36 p.m. Session Six: Revision Total Hip Arthroplasty Moderators:
John J. Callaghan, MD
David G. Lewallen, MD
4:40 p.m.
Paper #34
A Multi-Center Randomized Clinical Trial of Tranexamic Acid in Revision Total Hip Arthroplasty: Does the Dosing Regimen Matter? Robert A. Sershon, MD
Alexandria, VA
4:46 p.m.
Paper #35
 Is There a Benefit to Modularity for Femoral Revisions When Using a Splined, Tapered Titanium Stem? Matthew R. Cohn, MD
Chicago, IL
4:52 p.m.
Paper #36
Projections and Epidemiology of Revision Hip and Knee Arthroplasty in The United States to 2030 Andrew M. Schwartz, MD
Atlanta, GA
4:58 p.m. Discussion
5:08 p.m.
Paper #37
Outcome of Re-Revision Surgery for Adverse Local Tissue Reaction in Metal-on-Polyethylene and Metal-on-Metal Total Hip Arthroplasty Young-Min Kwon, MD, PhD
Boston, MA
5:14 p.m.
Paper #38
Patients Following Revision Total Hip Arthroplasty with Modular Dual Mobility Components Are at Risk of Increased Serum Metal Ion Levels Roberto Civinini, MD
Firenze, Italy
5:20 p.m.
Paper #39
Serum Metal Ion Levels following Total Hip Arthroplasty: A Comparison Between Monoblock and Modular Dual Mobility Components Ivan De Martino, MD
New York, NY
5:26 p.m. Discussion
5:36 – 6:27 p.m. Symposium VI: Tips and Tricks to Save You During Revision TKAs:  Video-Based Demonstrations

  • Exposures and Component Removal: It Is an Art!
    Craig J. Della Valle, M.D.
  • Cones, Sleeves, and Stems:  How to Manage Bone Loss and Optimize Fixation
    Daniel J. Berry, M.D.
  • Articulating and Non-Articulating Spacers: What Are the Options in 2019?
    R. Michael Meneghini, M.D.
  • Extensor Mechanism Disruptions: A Synthetic Mesh Reconstruction
    Matthew P. Abdel, M.D.
  • Discussion
    All Faculty
Moderator: Matthew P. Abdel, MD
Panelists: 
Daniel J. Berry, MD
Craig J. Della Valle, MD
R. Michael Meneghini, MD
6:27 – 6:30 p.m. In Memoriam: David S. Hungerford, MD
May 4, 1938 – March 2, 2019
Presented by:
TBD
6:30 – 8:00 p.m. Reception for All Attendees in the Poster Hall Chantilly Ballroom

Go to Sunday’s Schedule »

CME

The American Association of Hip and Knee Surgeons (AAHKS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Hip and Knee Surgeons (AAHKS) designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

AAHKS is committed to ensuring balance, independence, objectivity, and scientific rigor in their governance, programmatic, educational, and other activities.  Board members, educational planners, faculty and staff, and anyone involved in a CME activity must disclose all relevant financial relationships with ACCME-defined commercial interests (including those of spouses/domestic partners) within the last 12 months that actually or potentially could predispose or bias the individual to a particular decision, view, or goal in connection with the educational activity in which he or she is engaged.

Prior to the meeting, disclosures will be available for review here: